Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

2661 - 2670 of 44979 results found

Opportunistic pathogens increased and probiotics or short-chain fatty acid-producing bacteria decreased in the intestinal microbiota of pneumonia inpatients during SARS-CoV-2 Omicron variant epidemic

Date
Sunday, February 25, 2024 - 4:00 AM
Description
The global pandemic of COVID-19 has been over four years, and the role of intestinal microbiota in the occurrence and development of COVID-19 needs to be further clarified. During the outbreak of SARS-CoV-2 Omicron variant in China, we analyzed the

Prior Influenza Infection Mitigates SARS-CoV-2 Disease in Syrian Hamsters

Date
Saturday, February 24, 2024 - 4:00 AM
Description
Seasonal infection rates of individual viruses are influenced by synergistic or inhibitory interactions between coincident viruses. Endemic patterns of SARS-CoV-2 and influenza infection overlap seasonally in the Northern hemisphere and may be

Sotrovimab: A Review of Its Efficacy against SARS-CoV-2 Variants

Date
Saturday, February 24, 2024 - 4:00 AM
Description
Among the anti-Spike monoclonal antibodies (mAbs), the S-309 derivative sotrovimab was the most successful in having the longest temporal window of clinical use, showing a high degree of resiliency to SARS-CoV-2 evolution interrupted only by the

N-Glycan Profiles of Neuraminidase from Avian Influenza Viruses

Date
Saturday, February 24, 2024 - 4:00 AM
Description
The cleavage of sialic acids by neuraminidase (NA) facilitates the spread of influenza A virus (IV) descendants. Understanding the enzymatic activity of NA aids research into the transmission of IVs. An effective method for purifying NA was developed